Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurotrophic factor release supporting nerve repair/regeneration by mesenchymal stem cells refers to the process by which MSCs secrete a combination of growth factors, cytokines, and neurotrophins—including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), ciliary neurotrophic factor (CNTF), and others—that promote neuronal survival, axonal outgrowth, remyelination, and functional recovery after nerve injury. This secretion is largely paracrine, modulating the immune environment, supporting angiogenesis, and reducing cell death, and is considered the primary mechanism by which MSCs exert neuroregenerative effects. Currently, clinical translation is limited by safety, efficacy variability, and incomplete mechanistic understanding.
Paracrine secretion of neurotrophic factors (NGF, BDNF, GDNF, CNTF, etc.) supporting neuronal survival and axonal regeneration Immunomodulation (secretion of anti-inflammatory cytokines and growth factors) Enhancement of angiogenesis via released factors (VEGF, HGF, IGF) Inhibition of scar tissue formation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurotrophic factor release (by mesenchymal stem cells).